|
|
National Stock Number: 6505-01-505-6640
Federal Supply Class: 6505
National Item Identification Number: 015056640
Description: BUPROPION HYDROCHLORIDE TABLETS
|
Manufacturer Information:
03-0056 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA | NDC00173-0556-01 | 0J8T0 | HALEON US LP | ZYBAN | 0J8T0 | HALEON US LP | NDC00591-3543-60 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. | NDC00591-3543-76 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. | NDC43598-0863-60 | 4E8M8 | DR REDDY'S LABORATORIES, INC. |
|
Techincal Specification:
ACTIVE MEDICAMENT MEDICINAL STRENGTH | 150.000 MILLIGRAMS BUPROPION HYDROCHLORIDE ACTIVE INGREDIENT | ADMINISTRATION | ORAL | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 281604 | COATING FEATURE | FILM, NONENTERIC | LONG ACTION METHOD | EXTENDED RELEASE | PART NAME ASSIGNED BY CONTROLLING AGENCY | BUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET | PRIMARY CONTAINER CONTENT QUANTITY | 60.000 TABLETS | PRIMARY CONTAINER TYPE | BOTTLE | SPECIAL FEATURES | TO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS | SUPPLEMENTARY FEATURES | ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET | TOTAL PRIMARY CONTAINER QUANTITY | 1 |
|
|